DK3682241T4 - Pct og pro.adm som markorer til monitorering af antibiotikabehandling - Google Patents

Pct og pro.adm som markorer til monitorering af antibiotikabehandling

Info

Publication number
DK3682241T4
DK3682241T4 DK18765658.2T DK18765658T DK3682241T4 DK 3682241 T4 DK3682241 T4 DK 3682241T4 DK 18765658 T DK18765658 T DK 18765658T DK 3682241 T4 DK3682241 T4 DK 3682241T4
Authority
DK
Denmark
Prior art keywords
adm
markers
pro
pct
antibiotic treatment
Prior art date
Application number
DK18765658.2T
Other languages
Danish (da)
English (en)
Other versions
DK3682241T3 (da
Inventor
Darius Wilson
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59887051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3682241(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of DK3682241T3 publication Critical patent/DK3682241T3/da
Publication of DK3682241T4 publication Critical patent/DK3682241T4/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK18765658.2T 2017-09-13 2018-09-13 Pct og pro.adm som markorer til monitorering af antibiotikabehandling DK3682241T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17190913 2017-09-13
PCT/EP2018/074724 WO2019053117A1 (en) 2017-09-13 2018-09-13 PCT AND PRO-ADM USED AS CONTROL MARKERS IN ANTIBIOTIC TREATMENT

Publications (2)

Publication Number Publication Date
DK3682241T3 DK3682241T3 (da) 2022-05-16
DK3682241T4 true DK3682241T4 (da) 2025-10-06

Family

ID=59887051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18765658.2T DK3682241T4 (da) 2017-09-13 2018-09-13 Pct og pro.adm som markorer til monitorering af antibiotikabehandling

Country Status (10)

Country Link
US (1) US20200264199A1 (https=)
EP (2) EP3682241B2 (https=)
JP (2) JP7258860B2 (https=)
CN (1) CN111094981B (https=)
BR (1) BR112020004150A2 (https=)
CA (1) CA3075442C (https=)
DK (1) DK3682241T4 (https=)
ES (1) ES2913298T5 (https=)
WO (1) WO2019053117A1 (https=)
ZA (1) ZA202001108B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111094981B (zh) 2017-09-13 2024-04-16 B.R.A.H.M.S有限公司 Pct和pro-adm作为监测抗生素治疗的标记物
RU2724186C1 (ru) * 2020-01-23 2020-06-22 Наталья Борисовна Гусева Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
CN103123359B (zh) * 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
JP5989965B2 (ja) * 2008-01-08 2016-09-07 メルク シャープ エンド ドーム リミテッド 2−{4−[(3s)−ピペリジン−3−イル]フェニル}−2h−インダゾール−7−カルボキサミドの薬学的に許容される塩
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
EP2545379B1 (en) * 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
WO2012059477A1 (en) * 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
US11067586B2 (en) * 2011-11-16 2021-07-20 Sphingotec Gmbh Adrenomedullin assays and methods for determining mature adrenomedullin
EP2637023A1 (en) * 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
EP2976646B1 (en) * 2013-03-20 2020-08-19 sphingotec GmbH Adrenomedullin to guide therapy of blood pressure decline
CN111094981B (zh) 2017-09-13 2024-04-16 B.R.A.H.M.S有限公司 Pct和pro-adm作为监测抗生素治疗的标记物

Also Published As

Publication number Publication date
CN111094981B (zh) 2024-04-16
ZA202001108B (en) 2022-08-31
CA3075442C (en) 2024-04-02
EP3682241A1 (en) 2020-07-22
EP4027145A1 (en) 2022-07-13
RU2020111718A3 (https=) 2022-02-01
WO2019053117A1 (en) 2019-03-21
RU2020111718A (ru) 2021-10-13
EP3682241B2 (en) 2025-09-10
US20200264199A1 (en) 2020-08-20
JP7258860B2 (ja) 2023-04-17
JP2020533603A (ja) 2020-11-19
DK3682241T3 (da) 2022-05-16
ES2913298T3 (es) 2022-06-01
CN111094981A (zh) 2020-05-01
CA3075442A1 (en) 2019-03-21
EP3682241B1 (en) 2022-03-30
WO2019053117A8 (en) 2021-01-21
BR112020004150A2 (pt) 2020-09-08
ES2913298T5 (en) 2026-01-02
JP2023095851A (ja) 2023-07-06

Similar Documents

Publication Publication Date Title
DK3712150T3 (da) Makrocyklisk forbindelse, der tjener som wee1-hæmmer, og anvendelser deraf
DK3755356T3 (da) Sammensætninger, anordninger, systemer, sæt og fremgangsmåder til behandling af en hudtilstand
DK3676297T3 (da) Forbindelser, sammensætninger og fremgangsmåder
IL291150A (en) Systems, devices, and methods for forming an anastomosis
DK3247371T3 (da) Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil
DK3600456T3 (da) Fremgangsmåde til sterilisering
DK3580211T3 (da) 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer
EP3713931C0 (en) 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE
DK4428234T3 (da) Direkte-til-bibliotek-fremgangsmåder, systemer og sammensætninger
CL2019003599S1 (es) Extintor.
EP3654167A4 (en) OPERATING SYSTEM INSTALLATION
DK3545144T3 (da) Knudeelementer, kits og fremgangsmåder
DK3372671T3 (da) Dyrkningsmedium, som omfatter oligopeptider
DK3326971T3 (da) Antimikrobielt, insekticidt og akaricidt system
DK3781726T3 (da) Fotovoltaisk-elektrokemisk (pv-ec) system
DK3347360T3 (da) Forbindelser, som er anvendelige til inhibering af ror-gamma-t
EP3977774A4 (en) SIDE LINK SAFETY SETUP PROCEDURE
DK3232555T3 (da) Fremgangsmåde, indretning og system til fordelt styring af undermodul
DK3070964T3 (da) Høreapparat, især hørehjælpeapparat.
DK3191081T3 (da) Formulering, som omfatter glycopyrrolat, fremgangsmåde og indretning
DK3439641T3 (da) Sammensætninger, kits og fremgangsmåder til opretholselse af øjenlågshygiejne
DK3649043T3 (da) Flugtsystem
DK3621871T3 (da) Flugtsystem
DK3116238T3 (da) Afstandsstykke og høreanordning, som omfatter det
DK3682241T4 (da) Pct og pro.adm som markorer til monitorering af antibiotikabehandling